These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19303679

  • 21. Review on diagnosis and treatment of focal segmental glomerulosclerosis.
    Deegens JK, Steenbergen EJ, Wetzels JF.
    Neth J Med; 2008 Jan; 66(1):3-12. PubMed ID: 18219061
    [Abstract] [Full Text] [Related]

  • 22. A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis.
    Oliveira L, Wang D, McCormick BB.
    Ther Apher Dial; 2007 Jun; 11(3):227-31. PubMed ID: 17498006
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].
    Belovezhdov N.
    Vutr Boles; 1985 Jun; 24(1):40-9. PubMed ID: 4024608
    [Abstract] [Full Text] [Related]

  • 24. An update on the treatment options for focal segmental glomerulosclerosis.
    Meyrier A.
    Expert Opin Pharmacother; 2009 Mar; 10(4):615-28. PubMed ID: 19284364
    [Abstract] [Full Text] [Related]

  • 25. Coexistence of idiopathic membranous glomerulonephritis and idiopathic focal segmental glomerulosclerosis.
    Matsuo T, Mori Y, Hashimoto T, Tajima M, Okado T, Tsukamoto Y, Kobayashi Y, Sasaki S.
    Clin Nephrol; 2005 Dec; 64(6):490-2. PubMed ID: 16370166
    [No Abstract] [Full Text] [Related]

  • 26. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.
    Laurin LP, Gasim AM, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Foster BJ, Nachman PH.
    Clin J Am Soc Nephrol; 2016 Mar 07; 11(3):386-94. PubMed ID: 26912551
    [Abstract] [Full Text] [Related]

  • 27. Idiopathic focal and segmental glomerulosclerosis in Jamaica. A 10-year review.
    Barton EN, Williams W, Shah DJ, Miller M.
    West Indian Med J; 1995 Sep 07; 44(3):85-7. PubMed ID: 8560884
    [Abstract] [Full Text] [Related]

  • 28. Pulse methylprednisolone, cyclosporine, and ace inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis.
    Yorgin PD, Belson A, Higgins J, Alexander SR.
    Am J Kidney Dis; 2001 Jun 07; 37(6):E44. PubMed ID: 11382715
    [Abstract] [Full Text] [Related]

  • 29. Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis.
    Nadiminti U, Arbiser JL.
    J Am Acad Dermatol; 2005 Feb 07; 52(2 Suppl 1):17-9. PubMed ID: 15692505
    [Abstract] [Full Text] [Related]

  • 30. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
    Jayaraman VK, Thomas M.
    BMJ Case Rep; 2016 Feb 17; 2016():. PubMed ID: 26887886
    [Abstract] [Full Text] [Related]

  • 31. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
    Rangan GK, Coombes JD.
    Nephrol Dial Transplant; 2007 Aug 17; 22(8):2175-82. PubMed ID: 17550925
    [Abstract] [Full Text] [Related]

  • 32. Rapamycin attenuates the severity of murine adriamycin nephropathy.
    Lui SL, Tsang R, Chan KW, Zhang F, Tam S, Yung S, Chan TM.
    Am J Nephrol; 2009 Aug 17; 29(4):342-52. PubMed ID: 18948688
    [Abstract] [Full Text] [Related]

  • 33. Treatment of childhood steroid-resistant nephrotic syndrome with pulse methylprednisolone and cyclophosphamide.
    Sa GA, Luis JP, Mendonca E, Almeida M, Rosa FC.
    Pediatr Nephrol; 1996 Apr 17; 10(2):250. PubMed ID: 8703725
    [No Abstract] [Full Text] [Related]

  • 34. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 35. Possible mechanism by which rapamycin increases cyclosporine nephrotoxicity.
    Cheng CH, Chang HR, Chiang CW, Shu KH, Chou MC.
    Transplant Proc; 2008 Sep 15; 40(7):2373-5. PubMed ID: 18790238
    [Abstract] [Full Text] [Related]

  • 36. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A, Dial C, Ka EF, Lèye A, Pouye A, Ka MM, Mbengue M, Droz D, Diouf B.
    Dakar Med; 2008 Sep 15; 53(1):45-51. PubMed ID: 19102117
    [Abstract] [Full Text] [Related]

  • 37. Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: a case report.
    Couloures K, Pepkowitz SH, Goldfinger D, Kamil ES, Puliyanda DP.
    Pediatr Transplant; 2006 Dec 15; 10(8):962-5. PubMed ID: 17096767
    [Abstract] [Full Text] [Related]

  • 38. Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 cases.
    Soria A, Agbo-Godeau S, Taïeb A, Francès C.
    Dermatology; 2009 Dec 15; 218(1):22-5. PubMed ID: 18997452
    [Abstract] [Full Text] [Related]

  • 39. Morphometric and immunohistochemical insight into focal segmental glomerulosclerosis in obese and non-obese patients.
    Danilewicz M, Wagrowska-Danielwicz M.
    Nefrologia; 2009 Dec 15; 29(1):35-41. PubMed ID: 19240770
    [Abstract] [Full Text] [Related]

  • 40. Treatment of focal segmental glomerulosclerosis.
    Ponticelli CE, Glassock RJ.
    Kidney Int; 2010 Feb 15; 77(3):259; author reply 259. PubMed ID: 20075961
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.